Psoriatic arthritis trials in Bulgaria

In Bulgaria 7 Also abroad 116

7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
Phase 1Taking people
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Where
Lovech, Pleven, Plovdiv
Age
18 years and over
People
392 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07290036
Phase 3Taking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Pleven, Plovdiv, Ruse, Sofiya, Stara Zagora
Age
18 years and over
People
1,088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
Phase 3Taking people
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Where
Plovdiv, Sofia
Age
5 years to 17 years
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Pleven, Plovdiv, Sofiya, Stara Zagora
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 3Not yet taking people in Bulgaria
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
Where
Pleven, Plovdiv, Ruse, Sofia, Sofiya, Stara Zagora
Age
18 years and over
People
948 worldwide
Run by
MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00 · EU 2025-522471-28-00
No phaseTaking people
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Where
Pleven, Plovdiv, Sofia, Sofiya, Varna
Age
18 years to 75 years
People
1,200 worldwide
Run by
AbbVie
See details and how to joinNCT06764693